Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Cap table
Cap table
Built by 6ix from Cullinan Therapeutics, Inc.’s releases · as of Nov 4, 2026
- Common shares
- 64,920,924
- Fully diluted
- 64,920,924
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 64,920,924 | Nov 4, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 4, 2026 | 64,920,924 |